APA (7th ed.) Citation

M, K., I, C., E, V., A, S., T, L., C, G., . . . MF, B. (2022). Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target. Cancers, 14(16), . https://doi.org/10.3390/cancers14163918

Chicago Style (17th ed.) Citation

M, Koni, et al. "Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target." Cancers 14, no. 16 (2022). https://doi.org/10.3390/cancers14163918.

MLA (9th ed.) Citation

M, Koni, et al. "Interleukin-3-Receptor-α in Triple-Negative Breast Cancer (TNBC): An Additional Novel Biomarker of TNBC Aggressiveness and a Therapeutic Target." Cancers, vol. 14, no. 16, 2022, https://doi.org/10.3390/cancers14163918.